Plasma values of C reactive protein, a, proteinase inhibitor, a2 macroglobulin, and complexed a2 macroglobulin have been determined in serial samples from 27 patients with acute pancreatitis. Complexed a2 macroglobulin was measured by a novel enzyme linked immunosorbent assay with a monoclonal antibody specific for the complexed form. Patients with severe illness had lower concentrations of total a, macroglobulin and higher concentrations of complexed a2 macroglobulin than those with mild illness, and in the majority of severe attacks the abnormal amounts of complexed a2 macroglobulin were present throughout the eight days ofthe study. The proportion of total a2 macroglobulin in the uncomplexed form, however, was generally >90%, and in 26% of the mild cases completely normal concentrations of uncomplexed a2 macroglobulin (>99% of total) were found throughout the eight days of the study. This suggests that exhaustion of a2 macroglobulin in plasma is unlikely to be a major factor in the pathogenesis of acute pancreatitis.
During an attack of acute pancreatitis high concentrations of pancreatic secretory enzymes are found in plasma. Raised concentrations of proteases (trypsin, chymotrypsin, and elastase) can be detected using immunoassay techniques in attacks of all grades of severity, but these are present principally as zymogen (trypsinogen, chymotrypsinogen, and proelastase) with smaller amounts represented by proteases complexed with a, proteinase inhibitor, a2 macroglobulin, and a1 antichymotrypsin.' Protease activity cannot be detected in plasma during an attack of acute pancreatitis but evidence that active proteases are released is suggested by a fall in plasma concentrations of a2 macroglobulin especially in patients with severe attacks.`'0 a2 Macroglobulin is one of the principal proteinase inhibitors found in plasma, to which it is almost exclusively confined. It inhibits a broad spectrum of proteinases including trypsin." 12 Uniquely, the proteolytic activity of the bound proteinases is retained, although only towards low molecular weight substrates. This is explained by the 'trap' hypothesis'3 which proposes that the proteinase attacks a 'bait' region in the a2 macroglobulin molecule producing a conformational change to an electrophoretically 'fast' form,'4 together with physical entrapment of the proteinase molecule, while still permitting access to low molecular weight molecules.
In patients with acute pancreatitis a2 macro- Reference Unit, Royal Hallamshire Hospital, -__ ___ 6 Sheffield), and antiserum to C reactive protein and C reactive protein calibrant (Dako, High the 'severe' group than the 'mild' group, significantly so on days 1 and 2, but abnormally high values were found in both groups (Fig 1B) . When expressed as a percentage of total a2 macroglobulin the difference between.the two groups was more pronounced, with differences being significant on days 1, 2, 3, 6, and 7 ( Fig IC) . When individual patient data for complexed a2 macroglobulin were examined (Fig 2) , seven of eight patients classified as 'severe' had values of complexed a2 macroglobulin (whether expressed as absolute or relative) that were outside the normal range for the entire sampling period
The mean daily plasma concentrations of a, proteinase inhibitor and C reactive protein are shown in Figure 3A and B. Concentrations of a, proteinase inhibitor were raised in both groups, being higher in the severe group but not significantly. They peaked in both groups on day 6. Concentrations ofC reactive protein were high in both groups with significantly higher values in the severe grQup on days 1 to 6, the difference being most significant on days 2 and 3. Peak concentrations in both groups occurred on day 3. compared with seven of 19 the result of the release of proteolytic enzymes during the attack. Given the normally rapid removal of the complexed form of a2 macroglobulin from the circulation" the presence ofthe complexed form must be due to such a massive increase in complex formation that the transport processes responsible for the removal of the complexed material are overwhelmed, resulting in a steady state level of circulating complexes governed by the extent of enzyme liberation. Alternatively, the uptake and removal of the complexes may be impaired in pancreatitis. This would be consistent with an impairment of mononuclear phagocytosis in patients with severe acute pancreatitis (M J McMahon, unpublished observations). The pancreatic origin of the proteases complexed to a2 macroglobulin remains unconfirmed. Activation of zymogen is necessary before complex formation, but this might occur in or around the pancreas, in ascitic fluid, or in plasma. Activation of trypsin in the pancreas has been observed in experimental pancreatitis by Ohlsson.22 Particularly in severe pancreatitis, a2 macroglobulin in ascitic fluid may be present exclusively in complexes with protease.'6 Moreover, in a proportion ofpatients with severe acute pancreatitis digestion of fibrin plates by ascitic fluid has been shown,23 indicating protease activity. It is unlikely that the peritoneal mesothelium would be permeable to a2 macroglobulin-protease complexes, even during severe attacks of acute pancreatitis, but the opportunity to enter the plasma is provided by the thoracic duct, which may be an important route of transport between ascitic fluid and plasma during attacks. 24 Alternatively, activation of zymogen might occur in plasma, or activated proteases might be transported to the plasma in complexes with a, proteinase inhibitor, which can then transfer the enzyme to a2 macroglobulin. " The lower than normal concentrations of total plasma a2 macroglobulin found in this study, particularly in patients in the severe group, are in agreement with previously reported results.`0"'62 This presumably reflects the consumption of a2 macroglobulin by proteinases faster than it can be produced. This is supported by a small but significant inverse correlation (r=0-1861, p<0 05) between the complexed a2 macroglobulin and total a2 macroglobulin concentrations in the samples. 
